Toxicity mediated by soluble oligomers of β‐amyloid(1–42) on cholinergic SN56.B5.G4 cells
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is characterized by cholinergic dysfunction and progressive basal forebrain cell loss which has been assumed to be as a result of the extensive accumulation of β‐amyloid (Aβ). In addition to Aβ fibrillar assemblies, there are pre‐fibrillar forms that have been shown to be neurotoxic, although their role in cholinergic degeneration is still not known. Using the cholinergic cell line SN56.B5.G4, we investigated the effect of different Aβ(1–42) aggregates on cell viability. In our model, only soluble oligomeric but not fibrillar Aβ(1–42) forms induced toxicity in cholinergic cells. To determine whether the neurotoxicity of oligomeric Aβ(1–42) was caused by its oxidative potential, we performed microarray analysis of SN56.B5.G4 cells treated either with oligomeric Aβ(1–42) or H 2 O 2. We showed that genes affected by Aβ(1–42) differed from those affected by non‐specific oxidative stress. Many of the genes affected by Aβ(1–42) were present in the endoplasmic reticulum (ER), Golgi apparatus and/or otherwise involved in protein modification and degradation (chaperones, ATF6), indicating a possible role for ER‐mediated stress in Aβ‐mediated toxicity. Moreover, a number of genes, which are known to be involved in AD (clusterin, Slc18a3), were identified. This study provides important leads for the understanding of oligomeric Aβ(1–42) toxicity in cholinergic cells, which may account in part for cholinergic degeneration in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074 · cited 1×
“In cell culture experiments, it has been shown that Ab is able to produce hydrogen peroxide (Behl et al. 1994).”
BackgroundNeurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975 · cited 1×
“In addition to being neurotoxic, low concentrations of Ab can also function as neurotrophic factor (Whitson et al. 1989; Yankner et al. 1990).”
BackgroundRapid induction of Alzheimer A beta amyloid formation by zinc
Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522 · cited 1×
“…such as pH, ions (Cu2+ Fe2+ Zn2+) and the different solvents used influence the aggregation process (Barrow and Zagorski 1991; Mantyh et al. 1993; Bush et al. 1994; Atwood et al. 1998; Klug et al. 2003), so that there was some heterogeneity of aggregation states in the Ab composition used in…”
BackgroundProduction of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447 · cited 6×
“APPsw-transfected PC12 cells show an increased vulnerability after exposure to oxidative stress (Marques et al. 2003).”
BackgroundInfluentialNeurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086 · cited 1×
“Interestingly, Ab, in aqueous solution, has been reported to generate reactive oxygen species (Hensley et al. 1994).”
BackgroundGong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061 · cited 2×
“…diffusible ligands (ADDLs), respectively (Lambert et al. 1998; Kirkitadze et al. 2001; Walsh et al. 2002a; Bitan et al. 2003; Chromy et al. 2003; Gong et al. 2003), protofibrils (Harper et al. 1997; Walsh et al. 1999) in equilibrium with insoluble, high molecular weight fibrils (Teplow 1998;…”
BackgroundAmyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046 · cited 3×
“…(ADDLs), respectively (Lambert et al. 1998; Kirkitadze et al. 2001; Walsh et al. 2002a; Bitan et al. 2003; Chromy et al. 2003; Gong et al. 2003), protofibrils (Harper et al. 1997; Walsh et al. 1999) in equilibrium with insoluble, high molecular weight fibrils (Teplow 1998; Walsh et al. 1999).”
BackgroundBlalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., & Landfield, P. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308512100 · Cited by 1,025
Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M. E., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., & Bush, A. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12817 · Cited by 1,009 · cited 1×
“…pH, ions (Cu2+ Fe2+ Zn2+) and the different solvents used influence the aggregation process (Barrow and Zagorski 1991; Mantyh et al. 1993; Bush et al. 1994; Atwood et al. 1998; Klug et al. 2003), so that there was some heterogeneity of aggregation states in the Ab composition used in these studies.”
MethodER stress and neurodegenerative diseases
Lindholm, D., Wootz, H., & Korhonen, L. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401778 · Cited by 882 · cited 1×
“Recently, it has been described that ER stress plays a role in several neurological disorders such as AD (Imaizumi et al. 2001; Katayama et al. 2004; Lindholm et al. 2006).”
BackgroundAllan Butterfield, D. (2002) · Free Radical Research · doi:10.1080/1071576021000049890 · Cited by 786
IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649
Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells.
Busciglio, J., Gabuzda, D. H., Matsudaira, P., & Yankner, B. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.2092 · Cited by 569 · cited 1×
“…that Ab peptides derived by proteolytic cleavage of the endogenous transmembrane glycoprotein amyloid precursor protein (APP) (Shoji et al. 1992; Busciglio et al. 1993) induce neurodegenerative changes at cholinergic terminals (for review see Auld et al. 2002; Selkoe 2002; Dolezal and Kasparova…”
BackgroundDeibel, M. A., Ehmann, W. D., & Markesbery, W. R. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00203-1 · Cited by 540
Wang, H.-W., Pasternak, J. F., Kuo, H., Ristic, H., Lambert, M. P., Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B., Krafft, G. A., et al. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03058-x · Cited by 527 · cited 2×
“…electrophysiological changes and disruption of cognitive function (Hartley et al. 1999; Walsh et al. 1999; Walsh et al. 2002b; Kayed et al. 2003; Wang et al. 2002; Cleary et al. 2005), which may explain why early onset cholinergic dysfunction is in progress before there is considerable plaque…”
BackgroundSelf-Assembly of Aβ 1 - 42 into Globular Neurotoxins
Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., et al. (2003) · Biochemistry · doi:10.1021/bi030029q · Cited by 522 · cited 1×
“…and amyloid-derived diffusible ligands (ADDLs), respectively (Lambert et al. 1998; Kirkitadze et al. 2001; Walsh et al. 2002a; Bitan et al. 2003; Chromy et al. 2003; Gong et al. 2003), protofibrils (Harper et al. 1997; Walsh et al. 1999) in equilibrium with insoluble, high molecular weight…”
BackgroundYan, W., Frank, C. L., Korth, M. J., Sopher, B. L., Novoa, I., Ron, D., & Katze, M. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252341799 · Cited by 385 · cited 1×
“The chaperone Dnajc3 (P58IPK) is also known to be directly involved in the ER response because of its ability to inhibit the activity of PERK, which protects the cell by reducing the protein burden in ER (Yan et al. 2002).”
BackgroundOda, T., Wals, P., Osterburg, H. H., Johnson, S. A., Pasinetti, G. M., Morgan, T. E., Rozovsky, I., Stine, W. B., Snyder, S. W., Holzman, T. F., et al. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1080 · Cited by 352
May, P. C., Lampert-Etchells, M., Johnson, S. A., Poirier, J., Masters, J. N., & Finch, C. E. (1990) · Neuron · doi:10.1016/0896-6273(90)90342-d · Cited by 339 · cited 1×
“…vitro (Oda et al. 1995; Boggs et al. 1996; Matsubara et al. 1996), mediates the transport of soluble Ab in plasma and cerebrospinal fluid (Ghiso et al. 1993; Zlokovic 1996) and, not surprisingly, is present at high concentrations in the vicinity of AD plaques (May et al. 1990; Calero et al. 2000).”
Background(1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00056-1 · Cited by 330
Ghiso, J., Matsubara, E., Koudinov, A., Choi-Miura, N. H., Tomita, M., Wisniewski, T., & Frangione, B. (1993) · Biochemical Journal · doi:10.1042/bj2930027 · Cited by 304
The cholinergic innervation of the human cerebral cortex.
Mesulam, M.-M. (2004) · Progress in Brain Research · doi:10.1016/s0079-6123(03)45004-8 · Cited by 211 · cited 1×
“Cholinergic neurons of the basal forebrain, the site of origin of cholinergic afferents to hippocamus and cortex, are affected by neurodegeneration at early stages of the disease (Mesulam 2004).”
BackgroundWong, T. P., Debeir, T., Duff, K., & Cuello, A. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02706.1999 · Cited by 196 · cited 2×
“There are reports showing no change in VAChT expression in AD patients (Kish et al. 1990); increased expression of VAChT protein in AD-affected humans (Ruberg et al. 1990); and AD-related animal models (Wong et al. 1999; Hu et al. 2003; Klingner et al. 2003).”
BackgroundDelaère, P., Duyckaerts, C., Masters, C., Beyreuther, K., Piette, F., & Hauw, J.-J. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90391-l · Cited by 186
Hu, L., Wong, T. P., Côté, S. L., Bell, K. F. S., & Cuello, A. C. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00394-4 · Cited by 90
Differential gene expression in human brain pericytes induced by amyloid‐β protein
Rensink, A. A. M., Otte‐Höller, I., Donkelaar, H. J. T., De Waal, R. M. W., Kremer, B., & Verbeek, M. M. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00536.x · Cited by 24
Cited by
The cholinergic system in aging and neuronal degeneration
Schliebs, R., & Arendt, T. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.058 · Cited by 1,047
Self-citationThe Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
Cline, E. N., Bicca, M. A., Viola, K. L., & Klein, W. L. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179941 · Cited by 870
Rajmohan, R., & Reddy, P. H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160612 · Cited by 688
The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
Schliebs, R., & Arendt, T. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0579-2 · Cited by 530
Self-citationNeuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
Rojo, L. E., Fernández, J. A., Maccioni, A. A., Jimenez, J. M., & Maccioni, R. B. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.10.001 · Cited by 351
Metadata
- Authors
- Heinitz, K., Beck, M., Schliebs, R., & Perez‐Polo, J. R.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2006-07-10
- Volume
- 98
- Issue
- 6
- Pages
- 1930-1945
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1607451308
- Cited by
- 56
- References
- 29
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.